E4CPG 2 mg | 99.96%
TargetMol
E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
More Information Supplier PageE4CPG
Search Results
5-methoxyflavone 25 mg | 99.97%
TargetMol
5-methoxyflavone (5-methoxy-2-phenylchromen-4-one) is a naturally occurring, low molecular weight flavonoids compound that associated with a wide wariety of biological activities.
More Information Supplier Page5-methoxyflavone
Metadoxine 200 mg | Purity Not Available
TargetMol
Metadoxine
Epacadostat 25 mg | 98.56%
TargetMol
Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.
More Information Supplier PageEpacadostat
Epacadostat 100 mg | 98.56%
TargetMol
Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.
More Information Supplier PageEpacadostat
Epacadostat 200 mg | 98.56%
TargetMol
Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.
More Information Supplier PageEpacadostat
BTZ043 2 mg | 99.69%
TargetMol
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.
More Information Supplier PageBTZ043
PLX8394 25 mg | 100.00%
TargetMol
PLX8394 is an orally active inhibitor of serine/threonine-protein kinase B-Raf (BRAF) protein. PLX8394 can selectively bind to and inhibit the activity of both wild-type and mutated forms of BRAF, then inhibit the proliferation of tumor cells which express mutated forms of BRAF. PLX8394 appears to be effective against tumors that express multiple mutated forms of […]
More Information Supplier PagePLX8394
PLX8394 1 mg | 100.00%
TargetMol
PLX8394 is an orally active inhibitor of serine/threonine-protein kinase B-Raf (BRAF) protein. PLX8394 can selectively bind to and inhibit the activity of both wild-type and mutated forms of BRAF, then inhibit the proliferation of tumor cells which express mutated forms of BRAF. PLX8394 appears to be effective against tumors that express multiple mutated forms of […]
More Information Supplier PagePLX8394
NIH-12848 2 mg | 99.84%
TargetMol
NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) with an IC50 of 1 μM.
More Information Supplier PageNIH-12848
